On February 22, 2019, Roche Diabetes Care, Inc. (“Plaintiff”) filed a complaint against Valeritas, Inc. and Valeritas Holdings, Inc. (“Defendants”) for infringement of U.S. Patent No. 6,736,795 (“the ‘795 Patent”), which is owned by the Plaintiff and drawn to a device for administering an injectable product.
The Plaintiff is asserting that the Defendants are infringing at least claims 2 and 4 of the ‘795 Patent by manufacturing, using, offering for sale, selling, and/or importing V-Go disposable insulin delivery devices.
The case remains pending and is captioned 1:19-cv-00374 (D. Del.).
By: April Breyer Menon